Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Caremark May Offer Medicare Rx Plan If Risk Is Minimized, CEO Says

This article was originally published in The Pink Sheet Daily

Executive Summary

The risk corridor currently envisioned for stand-alone drug plans is too wide for Caremark to participate, but the PBM will consider offering a plan if the risk corridor is narrowed. Caremark also wants to avoid being perceived as a competitor by its health plan clients.

You may also be interested in...



Caremark Anticipates Modest Uptake For Medicare Rx Benefit In 2006

The PBM expects enrollment may not rise significantly until 2010 or later. Beneficiary participation in Part D could mirror the slow uptake of the drug discount card, CEO Crawford says, asserting that seniors "don't understand" the new benefit.

Caremark Anticipates Modest Uptake For Medicare Rx Benefit In 2006

The PBM expects enrollment may not rise significantly until 2010 or later. Beneficiary participation in Part D could mirror the slow uptake of the drug discount card, CEO Crawford says, asserting that seniors "don't understand" the new benefit.

Discount Card Enrollment Runs “Way Ahead” Of Similar Programs – McClellan

Enrollment in the Medicare drug discount card is outpacing all other previous voluntary programs at HHS, Centers for Medicare & Medicaid Services Administrator McClellan said

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058009

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel